Overview

Intravenous Dexamethasone for Ropivacaine Axillary Block

Status:
Completed
Trial end date:
2017-09-16
Target enrollment:
0
Participant gender:
All
Summary
Prospective monocentric double-blind controlled randomised trial Aim is to assess prolonged postsurgical analgesia by intravenous dexamethasone versus intravenous placebo, after ultrasound guided axillary brachial plexus block
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Treatments:
Anesthetics
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Ropivacaine
Criteria
Inclusion Criteria:

- ASA 1,2 et 3

- surgery under axillary brachial plexus block

- aged >18 years

- signed information consent

Exclusion Criteria:

- impaired coagulation

- contraindication to regional anesthesia or technical impossibility

- opioids or pain killers abuse or addiction

- steroids consumption in the past 6 months

- dementia or under administrative supervision

- delay of surgery to short to allow regional anesthesia

- pregnancy and breastfeeding

- allergy and contraindication to dexamethasone or ropivacaine

- anticipated bad observation of treatment

- patient enrolled in another trial